Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma
HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in...
GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Total revenues de creased by 18.2 % year over year to RMB 304.5 million (US$ 41.7 million) [1] . Net income was R MB -72.8million (US$-10.0 million) [1] compared to RMB8.6 million for the fourth quarter of 2023. Adjusted net income [2] was RMB 77 .3...
SWS Medical and Hemotek - Partners in Innovations at the 45th Philippine Society of Nephrology Annual Convention
MANILA, Philippines, April 24, 2025 /PRNewswire/ -- SWS Medical, a leading Chinese blood purification provider, is excited to participate in the 45th Philippine Society of Nephrology Annual Convention (April 24-26, 2025 Preferred Booth 1), the...
USANA Philippines Named Among Most Trusted Brands by Reader's Digest
Second consecutive year USANA won gold award in Natural Food Supplements category MANILA, Philippines, April 24, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, announced today that its Philippines market...
Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363（PD-1/IL-2α-bias）and Other Novel Drug Candidates at the 2025 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU,China, April 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
HYCO1 Signs a Memorandum of Understanding with Malaysia LNG Sdn. Bhd. to collaborate on a 1 Million Ton Per Annum Carbon Capture and Utilization Project in Bintulu, Sarawak, Malaysia
HOUSTON, April 23, 2025 /PRNewswire/ -- HYCO1, Inc. and Malaysia LNG Sdn. Bhd. signed a Memorandum of Understanding (MOU) to collaborate on the potential utilization and conversion of 1 Million Tons Per Annum (MTPA) of Carbon Dioxide (CO2). The...
PATEO Deepens Collaboration with Qualcomm to Deliver New Generation Intelligent Cockpit Solution Based on Snapdragon Cockpit Elite Platform
SHANGHAI, April 23, 2025 /PRNewswire/ -- PATEO CONNECT (hereinafter referred to as "PATEO") announced today an expanded collaboration with Qualcomm Technologies, Inc. to develop PATEO's new generation intelligent cockpit solution powered by the...
Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg
TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million (USD 4.5 million1) for the development of diagnostics for tuberculosis, in addition to an...
Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward
GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias Perjos, President & CEO at Getinge. The...
Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis
HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the National...